
Opinion|Videos|September 20, 2024
Current Advancements in Biomarker Research
The panel explores promising biomarker research that has the potential to significantly impact patient care in prostate cancer.
Advertisement
Episodes in this series

Video content above is prompted by the following question:
- What current advancements in biomarker research are you most excited about? (Brian Richardson, MD)
- Lysine-specific demethylase-1
- Appl1, Sortilin, and Syndecan-1
- Please highlight any others.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
3
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
4
BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC
5























